{"log_id": 2366974549709048649, "direction": 0, "words_result_num": 20, "words_result": [{"probability": {"variance": 0.00599, "average": 0.984955, "min": 0.509328}, "location": {"width": 828, "top": 234, "height": 28, "left": 205}, "words": "时,去羟肌酐肠溶剂的剂量应当减至每天200mg.联合给药时,富马酸替诺福韦二吡"}, {"probability": {"variance": 0.003344, "average": 0.984814, "min": 0.626755}, "location": {"width": 826, "top": 278, "height": 28, "left": 205}, "words": "呋酯和去羟肌酐肠溶剂可以在空腹状态下或与清淡食物(<400Kcal,20%脂肪)同"}, {"probability": {"variance": 5.5e-05, "average": 0.963443, "min": 0.956049}, "location": {"width": 24, "top": 264, "height": 25, "left": 1140}, "words": "主讠"}, {"probability": {"variance": 0, "average": 0.994659, "min": 0.994659}, "location": {"width": 28, "top": 300, "height": 26, "left": 1135}, "words": "骑"}, {"probability": {"variance": 6.1e-05, "average": 0.996255, "min": 0.957471}, "location": {"width": 829, "top": 321, "height": 32, "left": 204}, "words": "时给药。如需查阅富马酸替诺福韦二吡呋酯和去羟肌酐联合用药的更多信息,请参考"}, {"probability": {"variance": 0, "average": 0.999599, "min": 0.998964}, "location": {"width": 224, "top": 365, "height": 29, "left": 206}, "words": "去羟肌酐的完整说明书"}, {"probability": {"variance": 0.003026, "average": 0.989355, "min": 0.654989}, "location": {"width": 830, "top": 459, "height": 32, "left": 204}, "words": "阿扎那韦和洛匹那韦/利托那韦可使替诺福韦浓度增加。这种相互作用的机制尚未明确"}, {"probability": {"variance": 0.002125, "average": 0.99045, "min": 0.710576}, "location": {"width": 824, "top": 490, "height": 28, "left": 205}, "words": "在接受阿扎那韦和洛匹那韦/利托那韦和富马酸替诺福韦二吡呋酯的患者中,应当监测"}, {"probability": {"variance": 1.8e-05, "average": 0.997909, "min": 0.978784}, "location": {"width": 818, "top": 517, "height": 30, "left": 204}, "words": "其与富马酸替诺福韦二吡呋酯相关的不良反应。在出现与富马酸替诺福韦二吡呋酯相"}, {"probability": {"variance": 0.000147, "average": 0.994774, "min": 0.942322}, "location": {"width": 573, "top": 546, "height": 30, "left": 206}, "words": "关的不良事件的患者中,应当停用富马酸替诺福韦二吡呋酯"}, {"probability": {"variance": 0.009844, "average": 0.97845, "min": 0.369823}, "location": {"width": 803, "top": 598, "height": 28, "left": 206}, "words": "富马酸替诺福韦二吡呋酯能够降低阿扎那韦的AUC和Cmin与富马酸替诺福韦二吡"}, {"probability": {"variance": 0.000278, "average": 0.994021, "min": 0.910354}, "location": {"width": 827, "top": 626, "height": 30, "left": 206}, "words": "呋酯合用时,建议阿扎那韦300mg与利托那韦100mg同时给药。如果没有利托那韦"}, {"probability": {"variance": 1.8e-05, "average": 0.997827, "min": 0.982892}, "location": {"width": 486, "top": 657, "height": 26, "left": 205}, "words": "阿扎那韦不应与富马酸替诺福韦二吡呋酯联合给药"}, {"probability": {"variance": 1.9e-05, "average": 0.997954, "min": 0.97864}, "location": {"width": 816, "top": 708, "height": 31, "left": 206}, "words": "因为替诺福韦主要通过肾脏清除,所以富马酸替诺福韦二吡呋酯与能够导致肾功能减"}, {"probability": {"variance": 1.3e-05, "average": 0.998046, "min": 0.983896}, "location": {"width": 822, "top": 738, "height": 28, "left": 206}, "words": "低或与肾小管主动清除竞争的药物合用,能够使替诺福韦的血清浓度升高和或使其他"}, {"probability": {"variance": 0.000111, "average": 0.99603, "min": 0.941514}, "location": {"width": 815, "top": 769, "height": 26, "left": 206}, "words": "经肾脏清除的药物浓度增高。此类药物包括但不限于阿德福韦酯、西多福韦、阿昔洛"}, {"probability": {"variance": 9.8e-05, "average": 0.996277, "min": 0.953211}, "location": {"width": 815, "top": 797, "height": 28, "left": 207}, "words": "韦、万乃洛韦、更昔洛韦和缬更昔洛韦。降低肾功能的药物可能会使替诺福韦血清浓"}, {"probability": {"variance": 1.2e-05, "average": 0.996797, "min": 0.991925}, "location": {"width": 69, "top": 828, "height": 26, "left": 207}, "words": "度升高"}, {"probability": {"variance": 3.6e-05, "average": 0.997257, "min": 0.970506}, "location": {"width": 691, "top": 878, "height": 35, "left": 207}, "words": "富马酸替诺福韦二吡呋酯不应与阿德福韦酯联合给药治疗慢性乙肝。"}, {"probability": {"variance": 0, "average": 0.97683, "min": 0.97683}, "location": {"width": 51, "top": 927, "height": 48, "left": 1038}, "words": "它"}], "language": 3}